Faculty Opinions recommendation of Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

The Lancet ◽

10.1016/s0140-6736(10)61272-x ◽

2010 ◽

Vol 376 (9756) ◽

pp. 1916-1922 ◽

Cited By ~ 352

Author(s):

Vasilios G Athyros ◽

Konstantinos Tziomalos ◽

Thomas D Gossios ◽

Theodora Griva ◽

Panagiotis Anagnostis ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cardiovascular Events ◽

Statin Treatment ◽

Safety And Efficacy ◽

Post Hoc Analysis ◽

Post Hoc ◽

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

Yearbook of Pediatrics ◽

10.1016/j.yped.2011.06.024 ◽

2012 ◽

Vol 2012 ◽

pp. 203-205

Author(s):

J.A. Stockman

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cardiovascular Events ◽

Statin Treatment ◽

Safety And Efficacy ◽

Post Hoc Analysis ◽

Post Hoc ◽

Are statins safe for patients with abnormal liver function?Tziomalos K, Gossios TD, Griva T for the GREACE Study Collaborative Group (2010) Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 376: 1916–22

British Journal of Cardiac Nursing ◽

10.12968/bjca.2011.6.2.94a ◽

2011 ◽

Vol 6 (2) ◽

pp. 94-94 ◽

Cited By ~ 1

Author(s):

Belinda Linden

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cardiovascular Events ◽

Statin Treatment ◽

Abnormal Liver Function ◽

Collaborative Group ◽

Post Hoc Analysis ◽

Post Hoc ◽

Effects of 8,000 IU aXa long-term prophylaxis with certoparin on the incidence of hyperkalemia in patients with coronary heart disease – a post-hoc analysis of the PARAT trial

BMC Research Notes ◽

10.1186/1756-0500-7-880 ◽

2014 ◽

Vol 7 (1) ◽

pp. 880

Author(s):

Nima Melzer ◽

Peter Bramlage ◽

Hans-Christoph Michaelis

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Post Hoc Analysis ◽

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

International Journal of Cardiology ◽

10.1016/j.ijcard.2011.11.005 ◽

2012 ◽

Vol 154 (3) ◽

pp. 362-365 ◽

Cited By ~ 4

Author(s):

Jian-Jun Li ◽

Zong-Liang Lu ◽

Wen-Rong Kou ◽

Roberto Bolli ◽

Zuo Chen ◽

...

Keyword(s):

High Risk ◽

Secondary Prevention ◽

Cardiovascular Events ◽

Prevention Study ◽

Post Hoc Analysis ◽

Risk Patients ◽

Secondary Prevention Study ◽

Post Hoc ◽

Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE III for coronary heart disease patients

Journal of the Saudi Heart Association ◽

10.1016/j.jsha.2014.04.005 ◽

2014 ◽

Vol 26 (4) ◽

pp. 183-191 ◽

Cited By ~ 5

Author(s):

Fahad Alnouri ◽

David Wood ◽

Kornelia Kotseva ◽

Mohamed E.A. Ibrahim

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Lipid Level ◽

Post Hoc Analysis ◽

Euroaspire Iii ◽

Post Hoc ◽

European Registry

Long‐term trajectories of anxiety and depression in patients with stable coronary heart disease and risk of subsequent cardiovascular events

Depression and Anxiety ◽

10.1002/da.23011 ◽

2020 ◽

Vol 37 (8) ◽

pp. 784-792

Author(s):

Raphael S. Peter ◽

Michelle L. Meyer ◽

Ute Mons ◽

Ben Schöttker ◽

Ferdinand Keller ◽

...

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Cardiovascular Events ◽

Anxiety And Depression ◽

Stable Coronary Heart Disease

Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication)

Neuropsychopharmacology Reports ◽

10.1002/npr2.12107 ◽

2020 ◽

Vol 40 (2) ◽

pp. 122-129

Author(s):

Jun Ishigooka ◽

Tomohiro Usami ◽

Shuichi Iwashita ◽

Yoshitsugu Kojima ◽

Satoshi Matsuo

Keyword(s):

Japanese Patients ◽

Term Study ◽

Safety And Efficacy ◽

Post Hoc Analysis ◽

Long Term Study ◽

Faculty Opinions recommendation of Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725813090.793517374 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Coronary Heart Disease ◽

Heart Disease ◽

Clinical Outcomes ◽

Exercise Capacity ◽

Drug Evaluation ◽

Post Hoc Analysis ◽

Stable Coronary Heart Disease ◽

Evaluation Trial ◽

ALIROCUMAB REDUCES MAJOR CARDIOVASCULAR EVENTS IN INDIVIDUALS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A POST-HOC ANALYSIS OF ODYSSEY LONG TERM

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(17)33540-4 ◽

2017 ◽

Vol 69 (11) ◽

pp. 151

Author(s):

Jennifer Robinson ◽

Michel Farnier ◽

William J. Sasiela ◽

Tu Nguyen ◽

Jonas Mandel ◽

...

Keyword(s):

Cardiovascular Disease ◽

Cardiovascular Events ◽

Atherosclerotic Cardiovascular Disease ◽

Post Hoc Analysis ◽

Major Cardiovascular Events ◽